Cargando…
Anthracycline cardiotoxicity: current methods of diagnosis and possible role of (18)F-FDG PET/CT as a new biomarker
Despite advances in chemotherapy, the drugs used in cancer treatment remain rather harmful to the cardiovascular system, causing structural and functional cardiotoxic changes. Positron-emission tomography associated with computed tomography (PET/CT) has emerged like a promising technique in the earl...
Autores principales: | Becker, Mônica M. C., Arruda, Gustavo F. A., Berenguer, Diego R. F., Buril, Roberto O., Cardinale, Daniela, Brandão, Simone C. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041777/ https://www.ncbi.nlm.nih.gov/pubmed/36973762 http://dx.doi.org/10.1186/s40959-023-00161-6 |
Ejemplares similares
-
An image processing tool for the detection of anthracycline-induced cardiotoxicity by evaluating the myocardial metabolic activity in [(18)F]FDG PET/CT
por: Seiffert, Alexander P., et al.
Publicado: (2021) -
Cardiotoxicity of Anthracyclines
por: Cardinale, Daniela, et al.
Publicado: (2020) -
Oxidative stress and inflammation: determinants of anthracycline cardiotoxicity and possible therapeutic targets
por: Fabiani, Iacopo, et al.
Publicado: (2020) -
[(123)I]MIBG is a better early marker of anthracycline cardiotoxicity than [(18)F]FDG: a preclinical SPECT/CT and simultaneous PET/MR study
por: Oudot, Alexandra, et al.
Publicado: (2021) -
Anthracycline Cardiotoxicity: Can CT Move Us Further?
por: Campia, Umberto, et al.
Publicado: (2020)